Eligibility for treatment with the latest cancer drugs is often determined by genetic mutations in tumors, criteria that ...

Medical advancements make early-detected cancers more manageable and treatable, with immunotherapy and CAR T cell therapy ...

NEW YORK--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in New York and Memorial Sloan Kettering Cancer Center (MSK) announced today that the organizations have reached a new multi-year ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...

An expanding body of research indicates that aerobic exercise and strength-training can improve the chances of survival.

Anthem Blue Cross and Blue Shield in New York and Memorial Sloan Kettering Cancer Center (MSK) announced today that the organizations have reached a new multi-year agreement providing Anthem ...

2024--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in New York and Memorial Sloan Kettering Cancer Center (MSK) announced today that the organizations have reached a new multi-year agreement ...

Anthem Blue Cross Blue Shield and Memorial Sloan Kettering Cancer Center have reached a deal that keeps the premiere cancer treatment system in network, which helps patients maximize coverage.

Memorial Sloan Kettering Cancer Center and Anthem Blue Cross Blue Shield on Monday reached an agreement on reimbursement rates, sparing 22,000 patients on Long Island and elsewhere from being ...

And that was just one of many exciting discoveries made by MSK researchers in 2024. Researchers at Memorial Sloan Kettering Cancer Center (MSK) continued to make strides against cancer in 2024.